MPO Staff03.07.22
NanoVibronix Inc. is broadening its commercial reach in Europe.
The company has partnered with Medina Healthcare Ltd. in Malta to distribute its UroShield and PainShield devices.
"NanoVibronix have has already obtained regulatory approval to sell our range of devices into all European countries. We are eager to leverage Medina’s strong distribution capabilities in Malta and establish a foothold that will help us achieve broader distribution to other parts of Europe, NanoVibronix CEO Brian Murphy said. "Medina placed its initial order validating their confidence in our technology and the market potential for our devices. UroShield enables clinicians to potentially prevent the incidence of infections in the most vulnerable, and PainShield will empower patients to manage their chronic pain at a critical time for our healthcare system.”
UroShield is an ultrasound-based product designed to prevent bacterial colonization and biofilm on indwelling urinary catheters and increase antibiotic efficacy, ultimately reducing the incidence of catheter-associated urinary tract infections (CAUTI). UroShield also aims to decrease pain and discomfort associated with urinary catheter use.
PainShield is an ultrasound device, consisting of a reusable driver unit and a disposable patch, which contains a proprietary therapeutic transducer. PainShield delivers a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area, while keeping the level of ultrasound energy at a safe and consistent level. Its range of applications includes acute and chronic pain resolution through its many mechanisms of action. The product has been acknowledged by several sports icons and has broad applications for sports injuries. PainShield can be used by patients at home or work or in a clinical setting and can be used even while the patient is sleeping. Patient benefits include ease of application and use, faster recovery time, high compliance, and increased safety and efficacy over existing devices that rely on higher-frequency ultrasound.
“Following discussions with clinicians, we anticipate strong uptake of UroShield and PainShield devices as medical professionals seek minimally invasive, consumable devices that enable the delivery of the best therapies for their patients. The partnership with NanoVibronix allows us to provide solutions that both prevent the incidence of infections in the most vulnerable patients and help many people gain relief from chronic pain,” Medina Healthcare CEO John Soler said.
Medina Healthcare advances clinical education and has a high level of clinical and technical expertise along with an established, wide-ranging distribution network.
NanoVibronix is a medical device company developing medical devices that use its patented low intensity surface acoustic wave (SAW) technology, which allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disrupting biofilms and bacterial colonization, and for pain relief. The devices can be administered at home without the assistance of medical professionals. The company’s primary products include PainShield and UroShield, which are portable devices suitable for administration at home without assistance of medical professionals. NanoVibronix is headquartered in Elmsford, N.Y., with a research and development office in Nesher, Israel.
The company has partnered with Medina Healthcare Ltd. in Malta to distribute its UroShield and PainShield devices.
"NanoVibronix have has already obtained regulatory approval to sell our range of devices into all European countries. We are eager to leverage Medina’s strong distribution capabilities in Malta and establish a foothold that will help us achieve broader distribution to other parts of Europe, NanoVibronix CEO Brian Murphy said. "Medina placed its initial order validating their confidence in our technology and the market potential for our devices. UroShield enables clinicians to potentially prevent the incidence of infections in the most vulnerable, and PainShield will empower patients to manage their chronic pain at a critical time for our healthcare system.”
UroShield is an ultrasound-based product designed to prevent bacterial colonization and biofilm on indwelling urinary catheters and increase antibiotic efficacy, ultimately reducing the incidence of catheter-associated urinary tract infections (CAUTI). UroShield also aims to decrease pain and discomfort associated with urinary catheter use.
PainShield is an ultrasound device, consisting of a reusable driver unit and a disposable patch, which contains a proprietary therapeutic transducer. PainShield delivers a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area, while keeping the level of ultrasound energy at a safe and consistent level. Its range of applications includes acute and chronic pain resolution through its many mechanisms of action. The product has been acknowledged by several sports icons and has broad applications for sports injuries. PainShield can be used by patients at home or work or in a clinical setting and can be used even while the patient is sleeping. Patient benefits include ease of application and use, faster recovery time, high compliance, and increased safety and efficacy over existing devices that rely on higher-frequency ultrasound.
“Following discussions with clinicians, we anticipate strong uptake of UroShield and PainShield devices as medical professionals seek minimally invasive, consumable devices that enable the delivery of the best therapies for their patients. The partnership with NanoVibronix allows us to provide solutions that both prevent the incidence of infections in the most vulnerable patients and help many people gain relief from chronic pain,” Medina Healthcare CEO John Soler said.
Medina Healthcare advances clinical education and has a high level of clinical and technical expertise along with an established, wide-ranging distribution network.
NanoVibronix is a medical device company developing medical devices that use its patented low intensity surface acoustic wave (SAW) technology, which allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disrupting biofilms and bacterial colonization, and for pain relief. The devices can be administered at home without the assistance of medical professionals. The company’s primary products include PainShield and UroShield, which are portable devices suitable for administration at home without assistance of medical professionals. NanoVibronix is headquartered in Elmsford, N.Y., with a research and development office in Nesher, Israel.